Table 1.
N = 5216 | First eye | Second eye |
---|---|---|
Age | 77.7 ± 7.3 | 79.3 ± 7.9 |
Sex, Female | 69% | 69% |
CNV type | ||
Not classified | 20% | 25% |
Type 1 | 34% | 32% |
Type 2 | 30% | 27% |
RAP | 14% | 14% |
PCV | 2% | 2% |
Symptom duration | ||
<0–2 month | 40% | 39% |
2 ≤ 4 month | 25% | 24% |
4–6 month | 15% | 14% |
>6 month | 20% | 18% |
Visual Acuity | ||
ETDRS letters | 57.6 ± 15.4 | 62.8 ± 14.7*** |
Snellen | 0.35 ± 0.20 | 0.43 ± 0.23 |
At treatment start of first/second eye.
p < 0.0001.